Used primarily in pharmaceutical research as a selective dopamine reuptake inhibitor, this compound plays a key role in the development of treatments for central nervous system disorders. It is notably involved in studies related to attention-deficit/hyperactivity disorder (ADHD) and narcolepsy due to its ability to enhance dopaminergic transmission. Its structural configuration allows for high affinity binding to dopamine transporters, making it a valuable tool in neuropharmacology for understanding dopamine regulation. Additionally, it has been used as an intermediate in the synthesis of other bioactive molecules and receptor probes.